Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Novo Nordisk has acquired the global rights to China-based United Laboratories’ triple-agonist weight-loss and diabetes drug ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the ...

Fact checked by Nick Blackmer While GLP-1 drugs like Ozempic and Wegovy can lead to rapid and significant weight loss, they ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Everyone is talking about different diets that can help you lose weight, but do we really know what works and what doesn't?

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Around 5 million American women have PCOS, which plays into weight, reproductive health, and fertility outcomes. Here's ...

If you're losing more hair than usual, you could have a problem. Your diet may be to blame for your thinning mane.

Even a little weight loss can work wonders for your health. A study found that people at high risk for developing type 2 diabetes who lost 5-7% of their weight had a 58% lower risk of developing it.